| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.26 | 0.08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |